People: Infinity Pharmaceuticals Inc (INFI.O)

INFI.O on Nasdaq

12.73USD
24 Oct 2014
Price Change (% chg)

$-0.50 (-3.74%)
Prev Close
$13.22
Open
$13.28
Day's High
$13.79
Day's Low
$12.70
Volume
639,731
Avg. Vol
998,009
52-wk High
$18.35
52-wk Low
$8.40

Search Stocks

Perkins, Adelene 

Brief Biography

Ms. Adelene Q. Perkins is Chairman of the Board, President, Chief Executive Officer of Infinity Pharmaceuticals Inc. She has served as a member of board of directors and President and Chief Executive Officer since January 2010, including as chair of board of directors since November 2012, as President and Chief Business Officer from October 2008 through December 2009 and as Executive Vice President and Chief Business Officer between September 2006 and October 2008. Ms. Perkins served as Executive Vice President of Infinity Discovery, Inc. from February 2006 until the merger with predecessor company in September 2006 and Chief Business Officer of Infinity Discovery from June 2002 until September 2006. Ms. Perkins served as Vice President of Business and Corporate Development of TransForm Pharmaceuticals, Inc., a private pharmaceutical company, from 2000 to 2002. From 1992 to 1999, Ms. Perkins held various positions at Genetics Institute, most recently serving as Vice President of Emerging Business and General Manager of the DiscoverEaseĀ® business unit. From 1985 to 1992, Ms. Perkins held a variety of positions at Bain & Company, a strategy consulting firm. Ms. Perkins currently serves as a director of Project Hope, a not-for-profit social service company. Ms. Perkins received a B.S. in Chemical Engineering from Villanova University and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
552,000 -- 3,309,160 3,861,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adelene Perkins

3,861,160

Lawrence Bloch

1,090,810

Julian Adams

2,651,310

Vito Palombella

1,787,960

David Roth

--

Norman Selby

--
As Of 30 Dec 2013
Search Stocks